In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Transcatheter Aortic Valve Replacement in Low-Risk Patients at Five Years
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Another excellent podcast/video Joel. Great to hear Mike Mack explain things to us mere mortals.